Global Spine Biologics Supply, Demand and Key Producers, 2026-2032
The global Spine Biologics market size is expected to reach $ 3943 million by 2032, rising at a market growth of 6.2% CAGR during the forecast period (2026-2032).
Spine Biologics are implantable biological materials and regenerative products used in spinal fusion, bone-defect repair and spinal reconstruction to stimulate new bone formation, improve the local healing environment and increase the probability of successful fusion. Major categories include allograft bone, demineralized bone matrix, cellular bone matrices, synthetic bone-graft substitutes, recombinant bone morphogenetic proteins and collagen-based carrier systems. Depending on their composition, these products may provide an osteoconductive scaffold, osteoinductive biological signals or cells with osteogenic potential. They are generally used together with interbody cages, screws and fixation systems in cervical, thoracic and lumbar procedures for degenerative disease, deformity, trauma, tumor reconstruction and revision surgery. Their principal value is to reduce the additional morbidity associated with harvesting autologous bone while improving fusion predictability in complex or high-risk patients. In 2025, global Spine Biologics production reached approximately 1240 k units.The average gross profit margin of this product is 75%.
Population aging, the increasing burden of degenerative spinal disorders and the growing complexity and personalization of fusion procedures are supporting long-term demand for spine biologics. Compared with reliance on autograft alone, commercial biologic products can reduce donor-site pain and complications while providing additional support for patients with osteoporosis, multilevel fusion, spinal deformity or revision surgery. As navigation, robotics, minimally invasive approaches and advanced interbody devices become more widely adopted, biologics are evolving from supplementary graft materials into critical components influencing fusion quality, procedural efficiency and overall treatment value. The continued expansion of allograft, cellular matrix, synthetic graft and growth-factor portfolios by major spine companies further demonstrates their growing role within integrated spinal-care solutions.
The principal market constraints are clinical-evidence requirements, regulatory complexity and product-safety concerns. Materials differ in osteogenic performance, resorption profile, handling characteristics and patient suitability, making purchasing decisions increasingly dependent on long-term fusion evidence and real-world outcomes. Allograft and cellular products also require rigorous donor screening, infection control, tissue traceability and manufacturing consistency. Regulatory authorities impose strict requirements covering processing, storage and adverse-event management, while historical tissue-transmission events have increased hospital scrutiny of supply-chain safety. Recombinant growth-factor products must be used according to approved indications, dosages and application methods, as concerns regarding off-label use, local inflammatory responses and unwanted bone formation can influence clinical adoption and reimbursement.
Hospital and surgeon purchasing is shifting from selecting a general bone-filling material toward matching the biologic strategy to each patient?s fusion risk. Younger patients undergoing single-level procedures may prioritize affordability and ease of use, while elderly patients, those with poor bone quality and patients requiring multilevel or revision surgery place greater emphasis on biological performance and fusion certainty. Product formats are moving toward injectable, moldable and low-migration designs that can pass through minimally invasive access channels and integrate more closely with interbody-device architecture, surgical approach and digital preoperative planning. Products supported by comprehensive clinical evidence, consistent handling and multiple delivery formats are more likely to enter standardized hospital pathways and generate durable surgeon loyalty and recurring demand.
This report studies the global Spine Biologics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Spine Biologics and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Spine Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Spine Biologics total production and demand, 2021-2032, (K Units)
Global Spine Biologics total production value, 2021-2032, (USD Million)
Global Spine Biologics production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Spine Biologics consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Spine Biologics domestic production, consumption, key domestic manufacturers and share
Global Spine Biologics production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Spine Biologics production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Spine Biologics production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Spine Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet, Orthofix, Globus Medical, SeaSpine, Bioventus, Xtant Medical, Kuros Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Spine Biologics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Spine Biologics Market, By Region:
1. How big is the global Spine Biologics market?
2. What is the demand of the global Spine Biologics market?
3. What is the year over year growth of the global Spine Biologics market?
4. What is the production and production value of the global Spine Biologics market?
5. Who are the key producers in the global Spine Biologics market?
6. What are the growth factors driving the market demand?
Spine Biologics are implantable biological materials and regenerative products used in spinal fusion, bone-defect repair and spinal reconstruction to stimulate new bone formation, improve the local healing environment and increase the probability of successful fusion. Major categories include allograft bone, demineralized bone matrix, cellular bone matrices, synthetic bone-graft substitutes, recombinant bone morphogenetic proteins and collagen-based carrier systems. Depending on their composition, these products may provide an osteoconductive scaffold, osteoinductive biological signals or cells with osteogenic potential. They are generally used together with interbody cages, screws and fixation systems in cervical, thoracic and lumbar procedures for degenerative disease, deformity, trauma, tumor reconstruction and revision surgery. Their principal value is to reduce the additional morbidity associated with harvesting autologous bone while improving fusion predictability in complex or high-risk patients. In 2025, global Spine Biologics production reached approximately 1240 k units.The average gross profit margin of this product is 75%.
Population aging, the increasing burden of degenerative spinal disorders and the growing complexity and personalization of fusion procedures are supporting long-term demand for spine biologics. Compared with reliance on autograft alone, commercial biologic products can reduce donor-site pain and complications while providing additional support for patients with osteoporosis, multilevel fusion, spinal deformity or revision surgery. As navigation, robotics, minimally invasive approaches and advanced interbody devices become more widely adopted, biologics are evolving from supplementary graft materials into critical components influencing fusion quality, procedural efficiency and overall treatment value. The continued expansion of allograft, cellular matrix, synthetic graft and growth-factor portfolios by major spine companies further demonstrates their growing role within integrated spinal-care solutions.
The principal market constraints are clinical-evidence requirements, regulatory complexity and product-safety concerns. Materials differ in osteogenic performance, resorption profile, handling characteristics and patient suitability, making purchasing decisions increasingly dependent on long-term fusion evidence and real-world outcomes. Allograft and cellular products also require rigorous donor screening, infection control, tissue traceability and manufacturing consistency. Regulatory authorities impose strict requirements covering processing, storage and adverse-event management, while historical tissue-transmission events have increased hospital scrutiny of supply-chain safety. Recombinant growth-factor products must be used according to approved indications, dosages and application methods, as concerns regarding off-label use, local inflammatory responses and unwanted bone formation can influence clinical adoption and reimbursement.
Hospital and surgeon purchasing is shifting from selecting a general bone-filling material toward matching the biologic strategy to each patient?s fusion risk. Younger patients undergoing single-level procedures may prioritize affordability and ease of use, while elderly patients, those with poor bone quality and patients requiring multilevel or revision surgery place greater emphasis on biological performance and fusion certainty. Product formats are moving toward injectable, moldable and low-migration designs that can pass through minimally invasive access channels and integrate more closely with interbody-device architecture, surgical approach and digital preoperative planning. Products supported by comprehensive clinical evidence, consistent handling and multiple delivery formats are more likely to enter standardized hospital pathways and generate durable surgeon loyalty and recurring demand.
This report studies the global Spine Biologics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Spine Biologics and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Spine Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Spine Biologics total production and demand, 2021-2032, (K Units)
Global Spine Biologics total production value, 2021-2032, (USD Million)
Global Spine Biologics production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Spine Biologics consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Spine Biologics domestic production, consumption, key domestic manufacturers and share
Global Spine Biologics production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Spine Biologics production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Spine Biologics production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Spine Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet, Orthofix, Globus Medical, SeaSpine, Bioventus, Xtant Medical, Kuros Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Spine Biologics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Spine Biologics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Bone Graft
- Bone Graft Substitute
- Platelet Rich Plasma (PRP)
- BMAC (Bone Marrow Aspirate Concentrate)
- Lumbar Fusion
- Cervical Fusion
- Deformity Correction
- Revision Spine Surgery
- Other
- Putty
- Strip
- Granule
- Sponge/Collagen Carrier
- Other
- Spinal Fusion
- Bone Regeneration
- Orthopedic Reconstruction
- Minimally Invasive Spine Surgery
- Other
- Medtronic
- Stryker
- Johnson & Johnson
- Zimmer Biomet
- Orthofix
- Globus Medical
- SeaSpine
- Bioventus
- Xtant Medical
- Kuros Biosciences
- Beijing Chunlizhengda
- Bonovo Orthopedics
1. How big is the global Spine Biologics market?
2. What is the demand of the global Spine Biologics market?
3. What is the year over year growth of the global Spine Biologics market?
4. What is the production and production value of the global Spine Biologics market?
5. Who are the key producers in the global Spine Biologics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Spine Biologics Introduction
1.2 World Spine Biologics Supply & Forecast
1.2.1 World Spine Biologics Production Value (2021 & 2025 & 2032)
1.2.2 World Spine Biologics Production (2021-2032)
1.2.3 World Spine Biologics Pricing Trends (2021-2032)
1.3 World Spine Biologics Production by Region (Based on Production Site)
1.3.1 World Spine Biologics Production Value by Region (2021-2032)
1.3.2 World Spine Biologics Production by Region (2021-2032)
1.3.3 World Spine Biologics Average Price by Region (2021-2032)
1.3.4 North America Spine Biologics Production (2021-2032)
1.3.5 Europe Spine Biologics Production (2021-2032)
1.3.6 China Spine Biologics Production (2021-2032)
1.3.7 Japan Spine Biologics Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Spine Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Spine Biologics Major Market Trends
2 DEMAND SUMMARY
2.1 World Spine Biologics Demand (2021-2032)
2.2 World Spine Biologics Consumption by Region
2.2.1 World Spine Biologics Consumption by Region (2021-2026)
2.2.2 World Spine Biologics Consumption Forecast by Region (2027-2032)
2.3 United States Spine Biologics Consumption (2021-2032)
2.4 China Spine Biologics Consumption (2021-2032)
2.5 Europe Spine Biologics Consumption (2021-2032)
2.6 Japan Spine Biologics Consumption (2021-2032)
2.7 South Korea Spine Biologics Consumption (2021-2032)
2.8 ASEAN Spine Biologics Consumption (2021-2032)
2.9 India Spine Biologics Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Spine Biologics Production Value by Manufacturer (2021-2026)
3.2 World Spine Biologics Production by Manufacturer (2021-2026)
3.3 World Spine Biologics Average Price by Manufacturer (2021-2026)
3.4 Spine Biologics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Spine Biologics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Spine Biologics in 2025
3.5.3 Global Concentration Ratios (CR8) for Spine Biologics in 2025
3.6 Spine Biologics Market: Overall Company Footprint Analysis
3.6.1 Spine Biologics Market: Region Footprint
3.6.2 Spine Biologics Market: Company Product Type Footprint
3.6.3 Spine Biologics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Spine Biologics Production Value Comparison
4.1.1 United States VS China: Spine Biologics Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Spine Biologics Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Spine Biologics Production Comparison
4.2.1 United States VS China: Spine Biologics Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Spine Biologics Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Spine Biologics Consumption Comparison
4.3.1 United States VS China: Spine Biologics Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Spine Biologics Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Spine Biologics Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Spine Biologics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Spine Biologics Production Value (2021-2026)
4.4.3 United States Based Manufacturers Spine Biologics Production (2021-2026)
4.5 China Based Spine Biologics Manufacturers and Market Share
4.5.1 China Based Spine Biologics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Spine Biologics Production Value (2021-2026)
4.5.3 China Based Manufacturers Spine Biologics Production (2021-2026)
4.6 Rest of World Based Spine Biologics Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Spine Biologics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Spine Biologics Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Spine Biologics Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Spine Biologics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Bone Graft
5.2.2 Bone Graft Substitute
5.2.3 Platelet Rich Plasma (PRP)
5.2.4 BMAC (Bone Marrow Aspirate Concentrate)
5.3 Market Segment by Type
5.3.1 World Spine Biologics Production by Type (2021-2032)
5.3.2 World Spine Biologics Production Value by Type (2021-2032)
5.3.3 World Spine Biologics Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPINE PROCEDURE
6.1 World Spine Biologics Market Size Overview by Spine Procedure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Spine Procedure
6.2.1 Lumbar Fusion
6.2.2 Cervical Fusion
6.2.3 Deformity Correction
6.2.4 Revision Spine Surgery
6.2.5 Other
6.3 Market Segment by Spine Procedure
6.3.1 World Spine Biologics Production by Spine Procedure (2021-2032)
6.3.2 World Spine Biologics Production Value by Spine Procedure (2021-2032)
6.3.3 World Spine Biologics Average Price by Spine Procedure (2021-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World Spine Biologics Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Putty
7.2.2 Strip
7.2.3 Granule
7.2.4 Sponge/Collagen Carrier
7.2.5 Other
7.3 Market Segment by Product Form
7.3.1 World Spine Biologics Production by Product Form (2021-2032)
7.3.2 World Spine Biologics Production Value by Product Form (2021-2032)
7.3.3 World Spine Biologics Average Price by Product Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Spine Biologics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Spinal Fusion
8.2.2 Bone Regeneration
8.2.3 Orthopedic Reconstruction
8.2.4 Minimally Invasive Spine Surgery
8.2.5 Other
8.3 Market Segment by Application
8.3.1 World Spine Biologics Production by Application (2021-2032)
8.3.2 World Spine Biologics Production Value by Application (2021-2032)
8.3.3 World Spine Biologics Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Medtronic
9.1.1 Medtronic Details
9.1.2 Medtronic Major Business
9.1.3 Medtronic Spine Biologics Product and Services
9.1.4 Medtronic Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Medtronic Recent Developments/Updates
9.1.6 Medtronic Competitive Strengths & Weaknesses
9.2 Stryker
9.2.1 Stryker Details
9.2.2 Stryker Major Business
9.2.3 Stryker Spine Biologics Product and Services
9.2.4 Stryker Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Stryker Recent Developments/Updates
9.2.6 Stryker Competitive Strengths & Weaknesses
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Details
9.3.2 Johnson & Johnson Major Business
9.3.3 Johnson & Johnson Spine Biologics Product and Services
9.3.4 Johnson & Johnson Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Johnson & Johnson Recent Developments/Updates
9.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.4 Zimmer Biomet
9.4.1 Zimmer Biomet Details
9.4.2 Zimmer Biomet Major Business
9.4.3 Zimmer Biomet Spine Biologics Product and Services
9.4.4 Zimmer Biomet Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Zimmer Biomet Recent Developments/Updates
9.4.6 Zimmer Biomet Competitive Strengths & Weaknesses
9.5 Orthofix
9.5.1 Orthofix Details
9.5.2 Orthofix Major Business
9.5.3 Orthofix Spine Biologics Product and Services
9.5.4 Orthofix Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Orthofix Recent Developments/Updates
9.5.6 Orthofix Competitive Strengths & Weaknesses
9.6 Globus Medical
9.6.1 Globus Medical Details
9.6.2 Globus Medical Major Business
9.6.3 Globus Medical Spine Biologics Product and Services
9.6.4 Globus Medical Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Globus Medical Recent Developments/Updates
9.6.6 Globus Medical Competitive Strengths & Weaknesses
9.7 SeaSpine
9.7.1 SeaSpine Details
9.7.2 SeaSpine Major Business
9.7.3 SeaSpine Spine Biologics Product and Services
9.7.4 SeaSpine Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 SeaSpine Recent Developments/Updates
9.7.6 SeaSpine Competitive Strengths & Weaknesses
9.8 Bioventus
9.8.1 Bioventus Details
9.8.2 Bioventus Major Business
9.8.3 Bioventus Spine Biologics Product and Services
9.8.4 Bioventus Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bioventus Recent Developments/Updates
9.8.6 Bioventus Competitive Strengths & Weaknesses
9.9 Xtant Medical
9.9.1 Xtant Medical Details
9.9.2 Xtant Medical Major Business
9.9.3 Xtant Medical Spine Biologics Product and Services
9.9.4 Xtant Medical Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Xtant Medical Recent Developments/Updates
9.9.6 Xtant Medical Competitive Strengths & Weaknesses
9.10 Kuros Biosciences
9.10.1 Kuros Biosciences Details
9.10.2 Kuros Biosciences Major Business
9.10.3 Kuros Biosciences Spine Biologics Product and Services
9.10.4 Kuros Biosciences Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Kuros Biosciences Recent Developments/Updates
9.10.6 Kuros Biosciences Competitive Strengths & Weaknesses
9.11 Beijing Chunlizhengda
9.11.1 Beijing Chunlizhengda Details
9.11.2 Beijing Chunlizhengda Major Business
9.11.3 Beijing Chunlizhengda Spine Biologics Product and Services
9.11.4 Beijing Chunlizhengda Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Beijing Chunlizhengda Recent Developments/Updates
9.11.6 Beijing Chunlizhengda Competitive Strengths & Weaknesses
9.12 Bonovo Orthopedics
9.12.1 Bonovo Orthopedics Details
9.12.2 Bonovo Orthopedics Major Business
9.12.3 Bonovo Orthopedics Spine Biologics Product and Services
9.12.4 Bonovo Orthopedics Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Bonovo Orthopedics Recent Developments/Updates
9.12.6 Bonovo Orthopedics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Spine Biologics Industry Chain
10.2 Spine Biologics Upstream Analysis
10.2.1 Spine Biologics Core Raw Materials
10.2.2 Main Manufacturers of Spine Biologics Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Spine Biologics Production Mode
10.6 Spine Biologics Procurement Model
10.7 Spine Biologics Industry Sales Model and Sales Channels
10.7.1 Spine Biologics Sales Model
10.7.2 Spine Biologics Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Spine Biologics Introduction
1.2 World Spine Biologics Supply & Forecast
1.2.1 World Spine Biologics Production Value (2021 & 2025 & 2032)
1.2.2 World Spine Biologics Production (2021-2032)
1.2.3 World Spine Biologics Pricing Trends (2021-2032)
1.3 World Spine Biologics Production by Region (Based on Production Site)
1.3.1 World Spine Biologics Production Value by Region (2021-2032)
1.3.2 World Spine Biologics Production by Region (2021-2032)
1.3.3 World Spine Biologics Average Price by Region (2021-2032)
1.3.4 North America Spine Biologics Production (2021-2032)
1.3.5 Europe Spine Biologics Production (2021-2032)
1.3.6 China Spine Biologics Production (2021-2032)
1.3.7 Japan Spine Biologics Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Spine Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Spine Biologics Major Market Trends
2 DEMAND SUMMARY
2.1 World Spine Biologics Demand (2021-2032)
2.2 World Spine Biologics Consumption by Region
2.2.1 World Spine Biologics Consumption by Region (2021-2026)
2.2.2 World Spine Biologics Consumption Forecast by Region (2027-2032)
2.3 United States Spine Biologics Consumption (2021-2032)
2.4 China Spine Biologics Consumption (2021-2032)
2.5 Europe Spine Biologics Consumption (2021-2032)
2.6 Japan Spine Biologics Consumption (2021-2032)
2.7 South Korea Spine Biologics Consumption (2021-2032)
2.8 ASEAN Spine Biologics Consumption (2021-2032)
2.9 India Spine Biologics Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Spine Biologics Production Value by Manufacturer (2021-2026)
3.2 World Spine Biologics Production by Manufacturer (2021-2026)
3.3 World Spine Biologics Average Price by Manufacturer (2021-2026)
3.4 Spine Biologics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Spine Biologics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Spine Biologics in 2025
3.5.3 Global Concentration Ratios (CR8) for Spine Biologics in 2025
3.6 Spine Biologics Market: Overall Company Footprint Analysis
3.6.1 Spine Biologics Market: Region Footprint
3.6.2 Spine Biologics Market: Company Product Type Footprint
3.6.3 Spine Biologics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Spine Biologics Production Value Comparison
4.1.1 United States VS China: Spine Biologics Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Spine Biologics Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Spine Biologics Production Comparison
4.2.1 United States VS China: Spine Biologics Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Spine Biologics Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Spine Biologics Consumption Comparison
4.3.1 United States VS China: Spine Biologics Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Spine Biologics Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Spine Biologics Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Spine Biologics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Spine Biologics Production Value (2021-2026)
4.4.3 United States Based Manufacturers Spine Biologics Production (2021-2026)
4.5 China Based Spine Biologics Manufacturers and Market Share
4.5.1 China Based Spine Biologics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Spine Biologics Production Value (2021-2026)
4.5.3 China Based Manufacturers Spine Biologics Production (2021-2026)
4.6 Rest of World Based Spine Biologics Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Spine Biologics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Spine Biologics Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Spine Biologics Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Spine Biologics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Bone Graft
5.2.2 Bone Graft Substitute
5.2.3 Platelet Rich Plasma (PRP)
5.2.4 BMAC (Bone Marrow Aspirate Concentrate)
5.3 Market Segment by Type
5.3.1 World Spine Biologics Production by Type (2021-2032)
5.3.2 World Spine Biologics Production Value by Type (2021-2032)
5.3.3 World Spine Biologics Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPINE PROCEDURE
6.1 World Spine Biologics Market Size Overview by Spine Procedure: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Spine Procedure
6.2.1 Lumbar Fusion
6.2.2 Cervical Fusion
6.2.3 Deformity Correction
6.2.4 Revision Spine Surgery
6.2.5 Other
6.3 Market Segment by Spine Procedure
6.3.1 World Spine Biologics Production by Spine Procedure (2021-2032)
6.3.2 World Spine Biologics Production Value by Spine Procedure (2021-2032)
6.3.3 World Spine Biologics Average Price by Spine Procedure (2021-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World Spine Biologics Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Putty
7.2.2 Strip
7.2.3 Granule
7.2.4 Sponge/Collagen Carrier
7.2.5 Other
7.3 Market Segment by Product Form
7.3.1 World Spine Biologics Production by Product Form (2021-2032)
7.3.2 World Spine Biologics Production Value by Product Form (2021-2032)
7.3.3 World Spine Biologics Average Price by Product Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Spine Biologics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Spinal Fusion
8.2.2 Bone Regeneration
8.2.3 Orthopedic Reconstruction
8.2.4 Minimally Invasive Spine Surgery
8.2.5 Other
8.3 Market Segment by Application
8.3.1 World Spine Biologics Production by Application (2021-2032)
8.3.2 World Spine Biologics Production Value by Application (2021-2032)
8.3.3 World Spine Biologics Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Medtronic
9.1.1 Medtronic Details
9.1.2 Medtronic Major Business
9.1.3 Medtronic Spine Biologics Product and Services
9.1.4 Medtronic Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Medtronic Recent Developments/Updates
9.1.6 Medtronic Competitive Strengths & Weaknesses
9.2 Stryker
9.2.1 Stryker Details
9.2.2 Stryker Major Business
9.2.3 Stryker Spine Biologics Product and Services
9.2.4 Stryker Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Stryker Recent Developments/Updates
9.2.6 Stryker Competitive Strengths & Weaknesses
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Details
9.3.2 Johnson & Johnson Major Business
9.3.3 Johnson & Johnson Spine Biologics Product and Services
9.3.4 Johnson & Johnson Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Johnson & Johnson Recent Developments/Updates
9.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.4 Zimmer Biomet
9.4.1 Zimmer Biomet Details
9.4.2 Zimmer Biomet Major Business
9.4.3 Zimmer Biomet Spine Biologics Product and Services
9.4.4 Zimmer Biomet Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Zimmer Biomet Recent Developments/Updates
9.4.6 Zimmer Biomet Competitive Strengths & Weaknesses
9.5 Orthofix
9.5.1 Orthofix Details
9.5.2 Orthofix Major Business
9.5.3 Orthofix Spine Biologics Product and Services
9.5.4 Orthofix Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Orthofix Recent Developments/Updates
9.5.6 Orthofix Competitive Strengths & Weaknesses
9.6 Globus Medical
9.6.1 Globus Medical Details
9.6.2 Globus Medical Major Business
9.6.3 Globus Medical Spine Biologics Product and Services
9.6.4 Globus Medical Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Globus Medical Recent Developments/Updates
9.6.6 Globus Medical Competitive Strengths & Weaknesses
9.7 SeaSpine
9.7.1 SeaSpine Details
9.7.2 SeaSpine Major Business
9.7.3 SeaSpine Spine Biologics Product and Services
9.7.4 SeaSpine Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 SeaSpine Recent Developments/Updates
9.7.6 SeaSpine Competitive Strengths & Weaknesses
9.8 Bioventus
9.8.1 Bioventus Details
9.8.2 Bioventus Major Business
9.8.3 Bioventus Spine Biologics Product and Services
9.8.4 Bioventus Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bioventus Recent Developments/Updates
9.8.6 Bioventus Competitive Strengths & Weaknesses
9.9 Xtant Medical
9.9.1 Xtant Medical Details
9.9.2 Xtant Medical Major Business
9.9.3 Xtant Medical Spine Biologics Product and Services
9.9.4 Xtant Medical Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Xtant Medical Recent Developments/Updates
9.9.6 Xtant Medical Competitive Strengths & Weaknesses
9.10 Kuros Biosciences
9.10.1 Kuros Biosciences Details
9.10.2 Kuros Biosciences Major Business
9.10.3 Kuros Biosciences Spine Biologics Product and Services
9.10.4 Kuros Biosciences Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Kuros Biosciences Recent Developments/Updates
9.10.6 Kuros Biosciences Competitive Strengths & Weaknesses
9.11 Beijing Chunlizhengda
9.11.1 Beijing Chunlizhengda Details
9.11.2 Beijing Chunlizhengda Major Business
9.11.3 Beijing Chunlizhengda Spine Biologics Product and Services
9.11.4 Beijing Chunlizhengda Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Beijing Chunlizhengda Recent Developments/Updates
9.11.6 Beijing Chunlizhengda Competitive Strengths & Weaknesses
9.12 Bonovo Orthopedics
9.12.1 Bonovo Orthopedics Details
9.12.2 Bonovo Orthopedics Major Business
9.12.3 Bonovo Orthopedics Spine Biologics Product and Services
9.12.4 Bonovo Orthopedics Spine Biologics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Bonovo Orthopedics Recent Developments/Updates
9.12.6 Bonovo Orthopedics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Spine Biologics Industry Chain
10.2 Spine Biologics Upstream Analysis
10.2.1 Spine Biologics Core Raw Materials
10.2.2 Main Manufacturers of Spine Biologics Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Spine Biologics Production Mode
10.6 Spine Biologics Procurement Model
10.7 Spine Biologics Industry Sales Model and Sales Channels
10.7.1 Spine Biologics Sales Model
10.7.2 Spine Biologics Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Spine Biologics Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Spine Biologics Production Value by Region (2021-2026) & (USD Million)
Table 3. World Spine Biologics Production Value by Region (2027-2032) & (USD Million)
Table 4. World Spine Biologics Production Value Market Share by Region (2021-2026)
Table 5. World Spine Biologics Production Value Market Share by Region (2027-2032)
Table 6. World Spine Biologics Production by Region (2021-2026) & (K Units)
Table 7. World Spine Biologics Production by Region (2027-2032) & (K Units)
Table 8. World Spine Biologics Production Market Share by Region (2021-2026)
Table 9. World Spine Biologics Production Market Share by Region (2027-2032)
Table 10. World Spine Biologics Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Spine Biologics Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Spine Biologics Major Market Trends
Table 13. World Spine Biologics Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Spine Biologics Consumption by Region (2021-2026) & (K Units)
Table 15. World Spine Biologics Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Spine Biologics Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Spine Biologics Producers in 2025
Table 18. World Spine Biologics Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Spine Biologics Producers in 2025
Table 20. World Spine Biologics Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Spine Biologics Company Evaluation Quadrant
Table 22. World Spine Biologics Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Spine Biologics Production Site of Key Manufacturer
Table 24. Spine Biologics Market: Company Product Type Footprint
Table 25. Spine Biologics Market: Company Product Application Footprint
Table 26. Spine Biologics Competitive Factors
Table 27. Spine Biologics New Entrant and Capacity Expansion Plans
Table 28. Spine Biologics Mergers & Acquisitions Activity
Table 29. United States VS China Spine Biologics Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Spine Biologics Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Spine Biologics Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Spine Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Spine Biologics Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Spine Biologics Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Spine Biologics Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Spine Biologics Production Market Share (2021-2026)
Table 37. China Based Spine Biologics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Spine Biologics Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Spine Biologics Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Spine Biologics Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Spine Biologics Production Market Share (2021-2026)
Table 42. Rest of World Based Spine Biologics Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Spine Biologics Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Spine Biologics Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Spine Biologics Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Spine Biologics Production Market Share (2021-2026)
Table 47. World Spine Biologics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Spine Biologics Production by Type (2021-2026) & (K Units)
Table 49. World Spine Biologics Production by Type (2027-2032) & (K Units)
Table 50. World Spine Biologics Production Value by Type (2021-2026) & (USD Million)
Table 51. World Spine Biologics Production Value by Type (2027-2032) & (USD Million)
Table 52. World Spine Biologics Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Spine Biologics Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Spine Biologics Production Value by Spine Procedure, (USD Million), 2021 & 2025 & 2032
Table 55. World Spine Biologics Production by Spine Procedure (2021-2026) & (K Units)
Table 56. World Spine Biologics Production by Spine Procedure (2027-2032) & (K Units)
Table 57. World Spine Biologics Production Value by Spine Procedure (2021-2026) & (USD Million)
Table 58. World Spine Biologics Production Value by Spine Procedure (2027-2032) & (USD Million)
Table 59. World Spine Biologics Average Price by Spine Procedure (2021-2026) & (USD/Unit)
Table 60. World Spine Biologics Average Price by Spine Procedure (2027-2032) & (USD/Unit)
Table 61. World Spine Biologics Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Spine Biologics Production by Product Form (2021-2026) & (K Units)
Table 63. World Spine Biologics Production by Product Form (2027-2032) & (K Units)
Table 64. World Spine Biologics Production Value by Product Form (2021-2026) & (USD Million)
Table 65. World Spine Biologics Production Value by Product Form (2027-2032) & (USD Million)
Table 66. World Spine Biologics Average Price by Product Form (2021-2026) & (USD/Unit)
Table 67. World Spine Biologics Average Price by Product Form (2027-2032) & (USD/Unit)
Table 68. World Spine Biologics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Spine Biologics Production by Application (2021-2026) & (K Units)
Table 70. World Spine Biologics Production by Application (2027-2032) & (K Units)
Table 71. World Spine Biologics Production Value by Application (2021-2026) & (USD Million)
Table 72. World Spine Biologics Production Value by Application (2027-2032) & (USD Million)
Table 73. World Spine Biologics Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Spine Biologics Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Medtronic Basic Information, Manufacturing Base and Competitors
Table 76. Medtronic Major Business
Table 77. Medtronic Spine Biologics Product and Services
Table 78. Medtronic Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Medtronic Recent Developments/Updates
Table 80. Medtronic Competitive Strengths & Weaknesses
Table 81. Stryker Basic Information, Manufacturing Base and Competitors
Table 82. Stryker Major Business
Table 83. Stryker Spine Biologics Product and Services
Table 84. Stryker Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Stryker Recent Developments/Updates
Table 86. Stryker Competitive Strengths & Weaknesses
Table 87. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 88. Johnson & Johnson Major Business
Table 89. Johnson & Johnson Spine Biologics Product and Services
Table 90. Johnson & Johnson Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Johnson & Johnson Recent Developments/Updates
Table 92. Johnson & Johnson Competitive Strengths & Weaknesses
Table 93. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 94. Zimmer Biomet Major Business
Table 95. Zimmer Biomet Spine Biologics Product and Services
Table 96. Zimmer Biomet Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Zimmer Biomet Recent Developments/Updates
Table 98. Zimmer Biomet Competitive Strengths & Weaknesses
Table 99. Orthofix Basic Information, Manufacturing Base and Competitors
Table 100. Orthofix Major Business
Table 101. Orthofix Spine Biologics Product and Services
Table 102. Orthofix Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Orthofix Recent Developments/Updates
Table 104. Orthofix Competitive Strengths & Weaknesses
Table 105. Globus Medical Basic Information, Manufacturing Base and Competitors
Table 106. Globus Medical Major Business
Table 107. Globus Medical Spine Biologics Product and Services
Table 108. Globus Medical Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Globus Medical Recent Developments/Updates
Table 110. Globus Medical Competitive Strengths & Weaknesses
Table 111. SeaSpine Basic Information, Manufacturing Base and Competitors
Table 112. SeaSpine Major Business
Table 113. SeaSpine Spine Biologics Product and Services
Table 114. SeaSpine Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. SeaSpine Recent Developments/Updates
Table 116. SeaSpine Competitive Strengths & Weaknesses
Table 117. Bioventus Basic Information, Manufacturing Base and Competitors
Table 118. Bioventus Major Business
Table 119. Bioventus Spine Biologics Product and Services
Table 120. Bioventus Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bioventus Recent Developments/Updates
Table 122. Bioventus Competitive Strengths & Weaknesses
Table 123. Xtant Medical Basic Information, Manufacturing Base and Competitors
Table 124. Xtant Medical Major Business
Table 125. Xtant Medical Spine Biologics Product and Services
Table 126. Xtant Medical Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Xtant Medical Recent Developments/Updates
Table 128. Xtant Medical Competitive Strengths & Weaknesses
Table 129. Kuros Biosciences Basic Information, Manufacturing Base and Competitors
Table 130. Kuros Biosciences Major Business
Table 131. Kuros Biosciences Spine Biologics Product and Services
Table 132. Kuros Biosciences Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Kuros Biosciences Recent Developments/Updates
Table 134. Kuros Biosciences Competitive Strengths & Weaknesses
Table 135. Beijing Chunlizhengda Basic Information, Manufacturing Base and Competitors
Table 136. Beijing Chunlizhengda Major Business
Table 137. Beijing Chunlizhengda Spine Biologics Product and Services
Table 138. Beijing Chunlizhengda Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Beijing Chunlizhengda Recent Developments/Updates
Table 140. Beijing Chunlizhengda Competitive Strengths & Weaknesses
Table 141. Bonovo Orthopedics Basic Information, Manufacturing Base and Competitors
Table 142. Bonovo Orthopedics Major Business
Table 143. Bonovo Orthopedics Spine Biologics Product and Services
Table 144. Bonovo Orthopedics Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Bonovo Orthopedics Recent Developments/Updates
Table 146. Bonovo Orthopedics Competitive Strengths & Weaknesses
Table 147. Global Key Players of Spine Biologics Upstream (Raw Materials)
Table 148. Global Spine Biologics Typical Customers
Table 149. Spine Biologics Typical Distributors
Table 1. World Spine Biologics Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Spine Biologics Production Value by Region (2021-2026) & (USD Million)
Table 3. World Spine Biologics Production Value by Region (2027-2032) & (USD Million)
Table 4. World Spine Biologics Production Value Market Share by Region (2021-2026)
Table 5. World Spine Biologics Production Value Market Share by Region (2027-2032)
Table 6. World Spine Biologics Production by Region (2021-2026) & (K Units)
Table 7. World Spine Biologics Production by Region (2027-2032) & (K Units)
Table 8. World Spine Biologics Production Market Share by Region (2021-2026)
Table 9. World Spine Biologics Production Market Share by Region (2027-2032)
Table 10. World Spine Biologics Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Spine Biologics Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Spine Biologics Major Market Trends
Table 13. World Spine Biologics Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Spine Biologics Consumption by Region (2021-2026) & (K Units)
Table 15. World Spine Biologics Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Spine Biologics Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Spine Biologics Producers in 2025
Table 18. World Spine Biologics Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Spine Biologics Producers in 2025
Table 20. World Spine Biologics Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Spine Biologics Company Evaluation Quadrant
Table 22. World Spine Biologics Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Spine Biologics Production Site of Key Manufacturer
Table 24. Spine Biologics Market: Company Product Type Footprint
Table 25. Spine Biologics Market: Company Product Application Footprint
Table 26. Spine Biologics Competitive Factors
Table 27. Spine Biologics New Entrant and Capacity Expansion Plans
Table 28. Spine Biologics Mergers & Acquisitions Activity
Table 29. United States VS China Spine Biologics Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Spine Biologics Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Spine Biologics Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Spine Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Spine Biologics Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Spine Biologics Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Spine Biologics Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Spine Biologics Production Market Share (2021-2026)
Table 37. China Based Spine Biologics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Spine Biologics Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Spine Biologics Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Spine Biologics Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Spine Biologics Production Market Share (2021-2026)
Table 42. Rest of World Based Spine Biologics Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Spine Biologics Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Spine Biologics Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Spine Biologics Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Spine Biologics Production Market Share (2021-2026)
Table 47. World Spine Biologics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Spine Biologics Production by Type (2021-2026) & (K Units)
Table 49. World Spine Biologics Production by Type (2027-2032) & (K Units)
Table 50. World Spine Biologics Production Value by Type (2021-2026) & (USD Million)
Table 51. World Spine Biologics Production Value by Type (2027-2032) & (USD Million)
Table 52. World Spine Biologics Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Spine Biologics Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Spine Biologics Production Value by Spine Procedure, (USD Million), 2021 & 2025 & 2032
Table 55. World Spine Biologics Production by Spine Procedure (2021-2026) & (K Units)
Table 56. World Spine Biologics Production by Spine Procedure (2027-2032) & (K Units)
Table 57. World Spine Biologics Production Value by Spine Procedure (2021-2026) & (USD Million)
Table 58. World Spine Biologics Production Value by Spine Procedure (2027-2032) & (USD Million)
Table 59. World Spine Biologics Average Price by Spine Procedure (2021-2026) & (USD/Unit)
Table 60. World Spine Biologics Average Price by Spine Procedure (2027-2032) & (USD/Unit)
Table 61. World Spine Biologics Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Spine Biologics Production by Product Form (2021-2026) & (K Units)
Table 63. World Spine Biologics Production by Product Form (2027-2032) & (K Units)
Table 64. World Spine Biologics Production Value by Product Form (2021-2026) & (USD Million)
Table 65. World Spine Biologics Production Value by Product Form (2027-2032) & (USD Million)
Table 66. World Spine Biologics Average Price by Product Form (2021-2026) & (USD/Unit)
Table 67. World Spine Biologics Average Price by Product Form (2027-2032) & (USD/Unit)
Table 68. World Spine Biologics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Spine Biologics Production by Application (2021-2026) & (K Units)
Table 70. World Spine Biologics Production by Application (2027-2032) & (K Units)
Table 71. World Spine Biologics Production Value by Application (2021-2026) & (USD Million)
Table 72. World Spine Biologics Production Value by Application (2027-2032) & (USD Million)
Table 73. World Spine Biologics Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Spine Biologics Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Medtronic Basic Information, Manufacturing Base and Competitors
Table 76. Medtronic Major Business
Table 77. Medtronic Spine Biologics Product and Services
Table 78. Medtronic Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Medtronic Recent Developments/Updates
Table 80. Medtronic Competitive Strengths & Weaknesses
Table 81. Stryker Basic Information, Manufacturing Base and Competitors
Table 82. Stryker Major Business
Table 83. Stryker Spine Biologics Product and Services
Table 84. Stryker Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Stryker Recent Developments/Updates
Table 86. Stryker Competitive Strengths & Weaknesses
Table 87. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 88. Johnson & Johnson Major Business
Table 89. Johnson & Johnson Spine Biologics Product and Services
Table 90. Johnson & Johnson Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Johnson & Johnson Recent Developments/Updates
Table 92. Johnson & Johnson Competitive Strengths & Weaknesses
Table 93. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 94. Zimmer Biomet Major Business
Table 95. Zimmer Biomet Spine Biologics Product and Services
Table 96. Zimmer Biomet Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Zimmer Biomet Recent Developments/Updates
Table 98. Zimmer Biomet Competitive Strengths & Weaknesses
Table 99. Orthofix Basic Information, Manufacturing Base and Competitors
Table 100. Orthofix Major Business
Table 101. Orthofix Spine Biologics Product and Services
Table 102. Orthofix Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Orthofix Recent Developments/Updates
Table 104. Orthofix Competitive Strengths & Weaknesses
Table 105. Globus Medical Basic Information, Manufacturing Base and Competitors
Table 106. Globus Medical Major Business
Table 107. Globus Medical Spine Biologics Product and Services
Table 108. Globus Medical Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Globus Medical Recent Developments/Updates
Table 110. Globus Medical Competitive Strengths & Weaknesses
Table 111. SeaSpine Basic Information, Manufacturing Base and Competitors
Table 112. SeaSpine Major Business
Table 113. SeaSpine Spine Biologics Product and Services
Table 114. SeaSpine Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. SeaSpine Recent Developments/Updates
Table 116. SeaSpine Competitive Strengths & Weaknesses
Table 117. Bioventus Basic Information, Manufacturing Base and Competitors
Table 118. Bioventus Major Business
Table 119. Bioventus Spine Biologics Product and Services
Table 120. Bioventus Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bioventus Recent Developments/Updates
Table 122. Bioventus Competitive Strengths & Weaknesses
Table 123. Xtant Medical Basic Information, Manufacturing Base and Competitors
Table 124. Xtant Medical Major Business
Table 125. Xtant Medical Spine Biologics Product and Services
Table 126. Xtant Medical Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Xtant Medical Recent Developments/Updates
Table 128. Xtant Medical Competitive Strengths & Weaknesses
Table 129. Kuros Biosciences Basic Information, Manufacturing Base and Competitors
Table 130. Kuros Biosciences Major Business
Table 131. Kuros Biosciences Spine Biologics Product and Services
Table 132. Kuros Biosciences Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Kuros Biosciences Recent Developments/Updates
Table 134. Kuros Biosciences Competitive Strengths & Weaknesses
Table 135. Beijing Chunlizhengda Basic Information, Manufacturing Base and Competitors
Table 136. Beijing Chunlizhengda Major Business
Table 137. Beijing Chunlizhengda Spine Biologics Product and Services
Table 138. Beijing Chunlizhengda Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Beijing Chunlizhengda Recent Developments/Updates
Table 140. Beijing Chunlizhengda Competitive Strengths & Weaknesses
Table 141. Bonovo Orthopedics Basic Information, Manufacturing Base and Competitors
Table 142. Bonovo Orthopedics Major Business
Table 143. Bonovo Orthopedics Spine Biologics Product and Services
Table 144. Bonovo Orthopedics Spine Biologics Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Bonovo Orthopedics Recent Developments/Updates
Table 146. Bonovo Orthopedics Competitive Strengths & Weaknesses
Table 147. Global Key Players of Spine Biologics Upstream (Raw Materials)
Table 148. Global Spine Biologics Typical Customers
Table 149. Spine Biologics Typical Distributors
LIST OF FIGURES
Figure 1. Spine Biologics Picture
Figure 2. World Spine Biologics Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Spine Biologics Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Spine Biologics Production (2021-2032) & (K Units)
Figure 5. World Spine Biologics Average Price (2021-2032) & (USD/Unit)
Figure 6. World Spine Biologics Production Value Market Share by Region (2021-2032)
Figure 7. World Spine Biologics Production Market Share by Region (2021-2032)
Figure 8. North America Spine Biologics Production (2021-2032) & (K Units)
Figure 9. Europe Spine Biologics Production (2021-2032) & (K Units)
Figure 10. China Spine Biologics Production (2021-2032) & (K Units)
Figure 11. Japan Spine Biologics Production (2021-2032) & (K Units)
Figure 12. Spine Biologics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Spine Biologics Consumption (2021-2032) & (K Units)
Figure 15. World Spine Biologics Consumption Market Share by Region (2021-2032)
Figure 16. United States Spine Biologics Consumption (2021-2032) & (K Units)
Figure 17. China Spine Biologics Consumption (2021-2032) & (K Units)
Figure 18. Europe Spine Biologics Consumption (2021-2032) & (K Units)
Figure 19. Japan Spine Biologics Consumption (2021-2032) & (K Units)
Figure 20. South Korea Spine Biologics Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Spine Biologics Consumption (2021-2032) & (K Units)
Figure 22. India Spine Biologics Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Spine Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Spine Biologics Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Spine Biologics Markets in 2025
Figure 26. United States VS China: Spine Biologics Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Spine Biologics Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Spine Biologics Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Spine Biologics Production Market Share 2025
Figure 30. China Based Manufacturers Spine Biologics Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Spine Biologics Production Market Share 2025
Figure 32. World Spine Biologics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Spine Biologics Production Value Market Share by Type in 2025
Figure 34. Bone Graft
Figure 35. Bone Graft Substitute
Figure 36. Platelet Rich Plasma (PRP)
Figure 37. BMAC (Bone Marrow Aspirate Concentrate)
Figure 38. World Spine Biologics Production Market Share by Type (2021-2032)
Figure 39. World Spine Biologics Production Value Market Share by Type (2021-2032)
Figure 40. World Spine Biologics Average Price by Type (2021-2032) & (USD/Unit)
Figure 41. World Spine Biologics Production Value by Spine Procedure, (USD Million), 2021 & 2025 & 2032
Figure 42. World Spine Biologics Production Value Market Share by Spine Procedure in 2025
Figure 43. Lumbar Fusion
Figure 44. Cervical Fusion
Figure 45. Deformity Correction
Figure 46. Revision Spine Surgery
Figure 47. Other
Figure 48. World Spine Biologics Production Market Share by Spine Procedure (2021-2032)
Figure 49. World Spine Biologics Production Value Market Share by Spine Procedure (2021-2032)
Figure 50. World Spine Biologics Average Price by Spine Procedure (2021-2032) & (USD/Unit)
Figure 51. World Spine Biologics Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 52. World Spine Biologics Production Value Market Share by Product Form in 2025
Figure 53. Putty
Figure 54. Strip
Figure 55. Granule
Figure 56. Sponge/Collagen Carrier
Figure 57. Other
Figure 58. World Spine Biologics Production Market Share by Product Form (2021-2032)
Figure 59. World Spine Biologics Production Value Market Share by Product Form (2021-2032)
Figure 60. World Spine Biologics Average Price by Product Form (2021-2032) & (USD/Unit)
Figure 61. World Spine Biologics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Spine Biologics Production Value Market Share by Application in 2025
Figure 63. Spinal Fusion
Figure 64. Bone Regeneration
Figure 65. Orthopedic Reconstruction
Figure 66. Minimally Invasive Spine Surgery
Figure 67. Other
Figure 68. World Spine Biologics Production Market Share by Application (2021-2032)
Figure 69. World Spine Biologics Production Value Market Share by Application (2021-2032)
Figure 70. World Spine Biologics Average Price by Application (2021-2032) & (USD/Unit)
Figure 71. Spine Biologics Industry Chain
Figure 72. Spine Biologics Procurement Model
Figure 73. Spine Biologics Sales Model
Figure 74. Spine Biologics Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Spine Biologics Picture
Figure 2. World Spine Biologics Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Spine Biologics Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Spine Biologics Production (2021-2032) & (K Units)
Figure 5. World Spine Biologics Average Price (2021-2032) & (USD/Unit)
Figure 6. World Spine Biologics Production Value Market Share by Region (2021-2032)
Figure 7. World Spine Biologics Production Market Share by Region (2021-2032)
Figure 8. North America Spine Biologics Production (2021-2032) & (K Units)
Figure 9. Europe Spine Biologics Production (2021-2032) & (K Units)
Figure 10. China Spine Biologics Production (2021-2032) & (K Units)
Figure 11. Japan Spine Biologics Production (2021-2032) & (K Units)
Figure 12. Spine Biologics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Spine Biologics Consumption (2021-2032) & (K Units)
Figure 15. World Spine Biologics Consumption Market Share by Region (2021-2032)
Figure 16. United States Spine Biologics Consumption (2021-2032) & (K Units)
Figure 17. China Spine Biologics Consumption (2021-2032) & (K Units)
Figure 18. Europe Spine Biologics Consumption (2021-2032) & (K Units)
Figure 19. Japan Spine Biologics Consumption (2021-2032) & (K Units)
Figure 20. South Korea Spine Biologics Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Spine Biologics Consumption (2021-2032) & (K Units)
Figure 22. India Spine Biologics Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Spine Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Spine Biologics Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Spine Biologics Markets in 2025
Figure 26. United States VS China: Spine Biologics Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Spine Biologics Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Spine Biologics Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Spine Biologics Production Market Share 2025
Figure 30. China Based Manufacturers Spine Biologics Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Spine Biologics Production Market Share 2025
Figure 32. World Spine Biologics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Spine Biologics Production Value Market Share by Type in 2025
Figure 34. Bone Graft
Figure 35. Bone Graft Substitute
Figure 36. Platelet Rich Plasma (PRP)
Figure 37. BMAC (Bone Marrow Aspirate Concentrate)
Figure 38. World Spine Biologics Production Market Share by Type (2021-2032)
Figure 39. World Spine Biologics Production Value Market Share by Type (2021-2032)
Figure 40. World Spine Biologics Average Price by Type (2021-2032) & (USD/Unit)
Figure 41. World Spine Biologics Production Value by Spine Procedure, (USD Million), 2021 & 2025 & 2032
Figure 42. World Spine Biologics Production Value Market Share by Spine Procedure in 2025
Figure 43. Lumbar Fusion
Figure 44. Cervical Fusion
Figure 45. Deformity Correction
Figure 46. Revision Spine Surgery
Figure 47. Other
Figure 48. World Spine Biologics Production Market Share by Spine Procedure (2021-2032)
Figure 49. World Spine Biologics Production Value Market Share by Spine Procedure (2021-2032)
Figure 50. World Spine Biologics Average Price by Spine Procedure (2021-2032) & (USD/Unit)
Figure 51. World Spine Biologics Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 52. World Spine Biologics Production Value Market Share by Product Form in 2025
Figure 53. Putty
Figure 54. Strip
Figure 55. Granule
Figure 56. Sponge/Collagen Carrier
Figure 57. Other
Figure 58. World Spine Biologics Production Market Share by Product Form (2021-2032)
Figure 59. World Spine Biologics Production Value Market Share by Product Form (2021-2032)
Figure 60. World Spine Biologics Average Price by Product Form (2021-2032) & (USD/Unit)
Figure 61. World Spine Biologics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Spine Biologics Production Value Market Share by Application in 2025
Figure 63. Spinal Fusion
Figure 64. Bone Regeneration
Figure 65. Orthopedic Reconstruction
Figure 66. Minimally Invasive Spine Surgery
Figure 67. Other
Figure 68. World Spine Biologics Production Market Share by Application (2021-2032)
Figure 69. World Spine Biologics Production Value Market Share by Application (2021-2032)
Figure 70. World Spine Biologics Average Price by Application (2021-2032) & (USD/Unit)
Figure 71. Spine Biologics Industry Chain
Figure 72. Spine Biologics Procurement Model
Figure 73. Spine Biologics Sales Model
Figure 74. Spine Biologics Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
